Education
About Us
Working with TipRanks
Follow Us
Ecor1 Capital, Llc Insider Profile
4 Followers
Ecor1 Capital, Llc, Ten Percent Owner at Eiger Biopharmaceuticals, holds 17.88M shares in Zymeworks (Ticker: ZYME), holds 10.69M shares in iTeos Therapeutics (Ticker: ITOS), holds 5.30M shares in Prothena (Ticker: PRTA). Most recently, Ecor1 Capital, Llc Bought ― shares of Zymeworks on May 19, 2025 for an estimated value of 635.53K.
Ecor1 Capital, Llc Eiger Biopharmaceuticals (EIGRQ)Ten Percent Owner
Eiger Biopharmaceuticals (EIGRQ)
Ten Percent Owner
Ranked #25,867 out of 101,378 Corporate Insiders
Profitable Transactions
21 out of 42 Profitable Transactions
Average Return
+1.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Ecor1 Capital, Llc holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Oct 01, 2021 - Oct 01, 2022
Return:+82.90%
The most profitable trade made by Ecor1 Capital, Llc
Ecor1 Capital, Llc's Trading History
Eiger Biopharmaceuticals
Jun 30, 2015
―
Informative Buy
―
$24.17M
AKOUOS
Jul 02, 2020
―
Uninformative Buy
―
$26.26M
Surface Oncology
Sep 03, 2020
―
Informative Sell
2.38M
$5.03M
Prothena
May 06, 2025
Ten Percent Owner
Informative Sell
50.83M
$39.25M
AnaptysBio
Jan 02, 2025
Director, Ten Percent Owner
Informative Buy
1.10M
$161.31M
Corvus Pharmaceuticals
Oct 01, 2021
Ten Percent Owner
Informative Sell
25.04M
$293.50K
Odonate
Dec 10, 2021
Ten Percent Owner
Informative Buy
308.66K
$0.00
Voyager Therapeutics
Jan 11, 2023
Ten Percent Owner
Informative Sell
7.14M
$13.21M
Zymeworks
May 19, 2025
Director, Ten Percent Owner
Informative Buy
635.53K
$211.39M
Tango Therapeutics
Nov 08, 2024
Ten Percent Owner
Informative Sell
8.42M
$24.34M
Mersana Therapeutics
Dec 23, 2024
Ten Percent Owner
Uninformative Sell
―
$4.36M
iTeos Therapeutics
May 16, 2025
Ten Percent Owner
Informative Buy
38.68M
$89.89M
GenVec Inc
May 27, 2014
―
Informative Buy
54.04K
$6.92M
List of latest transactions for each holding click on a transaction to see Ecor1 Capital, Llc's performance on stock
You May Also Like
Ecor1 Capital, Llc insider profile FAQ
What is the percentage of profitable transactions made by Ecor1 Capital, Llc?
The percentage of profitable transactions made by Ecor1 Capital, Llc is 50%.
What is the average return per transaction made by Ecor1 Capital, Llc?
The average return per transaction made by Ecor1 Capital, Llc is 1.70%.
What stocks does Ecor1 Capital, Llc hold?
Ecor1 Capital, Llc holds: EIGRQ, AKUS, SURF, PRTA, ANAB, CRVS, ODTC, VYGR, ZYME, TNGX, MRSN, ITOS, GNVC stocks.
What was Ecor1 Capital, Llc’s latest transaction?
Ecor1 Capital, Llc latest transaction was an Informative Buy of $635.53K.
What was Ecor1 Capital, Llc's most profitable transaction?
Ecor1 Capital, Llc’s most profitable transaction was an Informative Sell of CRVS stock on October 1, 2021. The return on the trade was 82.90%.
What is Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals?
Ecor1 Capital, Llc's role in Eiger Biopharmaceuticals is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.